Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lifermann

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Annales De Medecine Interne|January 1, 1995
[Polycythemia secondary to pelvic leiomyosarcoma. Apropos of a case]T Mayet, D Lacoste, P Morlat, et al.
Annals of the Rheumatic Diseases|March 17, 2005
Neuropathy associated with leflunomide: a case seriesK Martin, F Bentaberry, C Dumoulin, et al.
La Revue De Medecine Interne|January 1, 1993
[Joint manifestations and parvovorus B19 infections: 8 cases]E Monlun, F Lifermann, C Lasseur, et al.
La Revue De Medecine Interne|August 17, 2024
[Neuropathy in a 56 year-old woman]F Blaison, R Prudencio, M Laborde, et al.
La Revue De Medecine Interne|August 16, 2000
[Hematologic and immunologic manifestations of primary cytomegalovirus infections in non-immunocompromised hospitalized adults]F Bonnet, P Morlat, D Neau, et al.
Annales De Medecine Interne|July 28, 2001
Clinical and laboratory findings of cytomegalovirus infection in 115 hospitalized non-immunocompromised adultsF Bonnet, D Neau, J F Viallard, et al.
Leukemia|April 19, 2013
Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosisJ Broséus, T Alpermann, M Wulfert, et al.
European Journal of Internal Medicine|October 30, 2021
Off-label use of biologics for the treatment of refractory and/or relapsing granulomatosis with polyangiitisC Mettler, C A Durel, P Guilpain, et al.
Allergy|August 27, 2016
Schnitzler syndrome: validation and applicability of diagnostic criteria in real-life patientsL Gusdorf, B Asli, S Barbarot, et al.
Leukemia|July 30, 2011
Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experienceH Avet-Loiseau, M Roussel, L Campion, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Annales De Medecine Interne|January 1, 1995
[Polycythemia secondary to pelvic leiomyosarcoma. Apropos of a case]T Mayet, D Lacoste, P Morlat, et al.
Annals of the Rheumatic Diseases|March 17, 2005
Neuropathy associated with leflunomide: a case seriesK Martin, F Bentaberry, C Dumoulin, et al.
La Revue De Medecine Interne|January 1, 1993
[Joint manifestations and parvovorus B19 infections: 8 cases]E Monlun, F Lifermann, C Lasseur, et al.
La Revue De Medecine Interne|August 17, 2024
[Neuropathy in a 56 year-old woman]F Blaison, R Prudencio, M Laborde, et al.
La Revue De Medecine Interne|August 16, 2000
[Hematologic and immunologic manifestations of primary cytomegalovirus infections in non-immunocompromised hospitalized adults]F Bonnet, P Morlat, D Neau, et al.
Annales De Medecine Interne|July 28, 2001
Clinical and laboratory findings of cytomegalovirus infection in 115 hospitalized non-immunocompromised adultsF Bonnet, D Neau, J F Viallard, et al.
Leukemia|April 19, 2013
Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosisJ Broséus, T Alpermann, M Wulfert, et al.
European Journal of Internal Medicine|October 30, 2021
Off-label use of biologics for the treatment of refractory and/or relapsing granulomatosis with polyangiitisC Mettler, C A Durel, P Guilpain, et al.
Allergy|August 27, 2016
Schnitzler syndrome: validation and applicability of diagnostic criteria in real-life patientsL Gusdorf, B Asli, S Barbarot, et al.
Leukemia|July 30, 2011
Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experienceH Avet-Loiseau, M Roussel, L Campion, et al.
Pageof 3